Literature DB >> 7726322

Double-blind, controlled trial of inositol treatment of depression.

J Levine1, Y Barak, M Gonzalves, H Szor, A Elizur, O Kofman, R H Belmaker.   

Abstract

OBJECTIVE: CSF levels of inositol have been reported to be lower than normal in depressed subjects. The authors administered inositol to depressed patients in a double-blind, controlled trial.
METHOD: Under double-blind conditions, 12 g/day of inositol (N = 13) or placebo (N = 15) was administered to depressed patients for 4 weeks.
RESULTS: The overall improvement in scores on the Hamilton Depression Rating Scale was significantly greater for inositol than for placebo at week 4. No changes were noted in hematology or in kidney or liver function.
CONCLUSIONS: This may be the first use of the precursor strategy for a second messenger rather than a neurotransmitter in treating depression. Although inositol had a significant antidepressant effect in this study, replication is crucial.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726322     DOI: 10.1176/ajp.152.5.792

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  29 in total

1.  Inositol treatment of autism.

Authors:  J Levine; A Aviram; A Holan; A Ring; Y Barak; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Inositol has behavioral effects with adaptation after chronic administration.

Authors:  H Cohen; M Kotler; Z Kaplan; M A Matar; O Kofman; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Effect of sleep efficiency on salivary metabolite profile and cognitive function during exercise in volleyball athletes.

Authors:  Nobuhiko Akazawa; Naoko Kobayashi; Yuki Nakamura; Hiroshi Kumagai; Youngju Choi; Seiji Maeda
Journal:  Eur J Appl Physiol       Date:  2019-08-12       Impact factor: 3.078

4.  Multi-tissue metabolic responses of goldfish (Carassius auratus) exposed to glyphosate-based herbicide.

Authors:  Ming-Hui Li; Hua-Dong Xu; Yan Liu; Ting Chen; Lei Jiang; Yong-Hong Fu; Jun-Song Wang
Journal:  Toxicol Res (Camb)       Date:  2016-04-15       Impact factor: 3.524

5.  Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways.

Authors:  Yaoyang Zhang; Michaela D Filiou; Stefan Reckow; Philipp Gormanns; Giuseppina Maccarrone; Melanie S Kessler; Elisabeth Frank; Boris Hambsch; Florian Holsboer; Rainer Landgraf; Christoph W Turck
Journal:  Mol Cell Proteomics       Date:  2011-08-23       Impact factor: 5.911

6.  Lithium treatment effects on Myo-inositol in adolescents with bipolar depression.

Authors:  Nick C Patel; Melissa P DelBello; Kim M Cecil; Caleb M Adler; Holly S Bryan; Kevin E Stanford; Stephen M Strakowski
Journal:  Biol Psychiatry       Date:  2006-11-01       Impact factor: 13.382

7.  A proteomic analysis of the ventral hippocampus of rats subjected to maternal separation and escitalopram treatment.

Authors:  Lelanie Marais; Suzél M Hattingh; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2009-10-16       Impact factor: 3.584

8.  Identification of myo-inositol-3-phosphate synthase isoforms: characterization, expression, and putative role of a 16-kDa gamma(c) isoform.

Authors:  Ratnam S Seelan; Jaganathan Lakshmanan; Manuel F Casanova; Ranga N Parthasarathy
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

Review 9.  Inositol for depressive disorders.

Authors:  M J Taylor; H Wilder; Z Bhagwagar; J Geddes
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Rat brain myo-inositol 3-phosphate synthase is a phosphoprotein.

Authors:  R N Parthasarathy; J Lakshmanan; M Thangavel; R S Seelan; J I Stagner; A J Janckila; R E Vadnal; M F Casanova; L K Parthasarathy
Journal:  Mol Cell Biochem       Date:  2013-03-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.